Vassiliki Papadimitrakopoulou, MD

Stephen M. Hahn, MD, FASTRO

Alice Shaw, MD

Key Findings from the CAR T-Cell Study Presented at the 2019 AACR Annual Meeting

Adjuvant EGFR-TKI for Resected NSCLC: Who, When, and Where?

Antibody–Drug Conjugates in NSCLC: Complexities, Challenges, and Potential

Luis E. Raez, MD

Consolidating Gains with Chemotherapy in SCLC Maintenance Trials: A Discussion with Dr. Shirish Gadgeel

Tackling TKI-Refractory Disease in Patients with Oncogenic Drivers: An Interview with Dr. Mark Socinski

Making Headway with Lorlatinib

Clinical Utility of Plasma Next-Generation Sequencing in Advanced NSCLC: Are We Ready for a ‘Blood-First’ Approach?

KEYNOTE-010: Long-Term Outcomes and Results of Retreatment